Endocrinology Unit, Azienda Ospedaliera Ordine Mauriziano di Torino, Largo Turati 62, Turin, Italy.
Thyroid. 2010 Oct;20(10):1077-83. doi: 10.1089/thy.2010.0015.
Fine-needle aspiration cytology (FNAC) has proved to be an effective diagnostic tool in patients with thyroid nodules. Several reporting schemes have been suggested to define the risk of malignancy and consequent clinical management. To date, however, among lesions showing a follicular pattern, FNAC is still unable to differentiate between benign and malignant ones. The aim of our study was to evaluate whether a subclassification of follicular cytologic specimens, based on cytoarchitectural patterns, could differentiate categories with a different risk of malignancy, thus improving the clinical management of patients harboring follicular nodules.
We report a cohort of 927 consecutive cases who underwent thyroid surgery in our hospital between 2000 and 2008. Each patient underwent FNAC before surgery. All the cytologic specimens were divided into five categories (Thy 1: inadequate material, Thy 2: benign, Thy 3: indeterminate, Thy 4: suspicious for malignancy, Thy 5: malignant). Thy3 specimens were further divided into three subcategories (Thy 3a, or "follicular lesions of indeterminate significance": scant colloid, microfollicular pattern, or small clusters of thyrocytes with round nuclei usually without, but sometimes with, minimal cellular pleomorphism; Thy 3b, or "follicular neoplasm": absence of colloid, small clusters, or microfollicles of medium-large sized cell populations arranged in cohesive groups with nuclear overlapping, crowding, and pleomorphisms; and Thy 3c or "Hurthle-cell neoplasm": scant colloid, sheets or clusters of oxyphilic cells).
Thy 1 specimens (51 cases on the whole) proved to be malignant in 5.88% (3 cases), Thy 2 specimens (319) in 3.45% (11 cases), Thy 4 specimens (91) in 84.62% (77 cases), and Thy 5 specimens (172) in 98.84% (170 cases). Thy 3 specimens (294 cases) proved to be malignant in 17.35% as a whole, but when divided into the three subcategories, the percentage of malignant cases was significantly different between the Thy 3a group (4.95%) and the Thy 3b and Thy 3c groups (25.0% and 22.77% respectively).
This study supports the National Cancer Institute consensus showing a different risk of malignancy for "follicular lesions of undetermined significance” compared with "follicular neoplasms" and "Hurthle cells neoplasms," which are more suspect for malignancy. This subclassification could improve clinical management of thyroid nodules, helping to better select patients for surgery or follow up.
细针穿刺细胞学检查(FNAC)已被证明是一种有效的诊断工具,可用于甲状腺结节患者。已经提出了几种报告方案来定义恶性肿瘤的风险和相应的临床管理。然而,迄今为止,在显示滤泡模式的病变中,FNAC 仍然无法区分良性和恶性病变。我们的研究目的是评估基于细胞结构模式的滤泡细胞学标本的细分是否可以区分具有不同恶性风险的类别,从而改善患有滤泡结节的患者的临床管理。
我们报告了 2000 年至 2008 年间在我们医院接受甲状腺手术的 927 例连续病例。每位患者在手术前均接受 FNAC 检查。所有细胞学标本均分为五类(Thy1:材料不足,Thy2:良性,Thy3:不确定,Thy4:疑似恶性,Thy5:恶性)。Thy3 标本进一步分为三个亚类(Thy3a,或“意义不明的滤泡性病变”:稀少的胶体,微滤泡模式,或小簇圆形细胞核的甲状腺细胞,通常没有,但有时有轻微的细胞多形性;Thy3b,或“滤泡性肿瘤”:无胶体,小簇或微滤泡,由中等大小的细胞群排列成具有核重叠、拥挤和多形性的凝聚群;Thy3c 或“嗜酸性细胞肿瘤”:稀少的胶体,密集的嗜酸细胞片或簇)。
Thy1 标本(共 51 例)恶性率为 5.88%(3 例),Thy2 标本(319 例)为 3.45%(11 例),Thy4 标本(91 例)为 84.62%(77 例),Thy5 标本(172 例)为 98.84%(170 例)。Thy3 标本(294 例)恶性率为 17.35%,但分为三个亚类后,Thy3a 组(4.95%)与 Thy3b 和 Thy3c 组(25.0%和 22.77%)的恶性病例比例有显著差异。
本研究支持美国国家癌症研究所的共识,即“意义不明的滤泡性病变”与“滤泡性肿瘤”和“嗜酸性细胞肿瘤”相比具有不同的恶性风险,后两者更具恶性嫌疑。这种细分可以改善甲状腺结节的临床管理,有助于更好地选择手术或随访的患者。